MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
PI3K/AKT/mTOR signaling in cancer
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,290 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,290 works in the cohort · of 4,299,418page 10 of 26

Labels cover 3 of 1,290 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,290 of 1,290 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
Ribavirin targets eIF4E dependent Akt survival signaling
Keith Tan, Biljana Čuljković, Abdellatif Amri, Katherine L. B. Borden
2008· article· en· Biochemical and Biophysical Research Communications· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
53
citations
afffundvenueunlabeled
mTORC1 and the regulation of skeletal muscle anabolism and mass
Olasunkanmi A. J. Adegoke, Abdikarim Abdullahi, Pegah Tavajohi‐Fini
2012· review· en· Applied Physiology Nutrition and Metabolism· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
51
citations
affunlabeled
PTEN deficiency: a role in mammary carcinogenesis
Teresa Petrocelli, Joyce M. Slingerland
2001· review· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
50
citations
affno abstractunlabeled
Tyrosine phosphorylation of SHIP promotes its proteasomal degradation
Jens Rüschmann, Victor W. Ho, Frann Antignano, Etsushi Kuroda, Vivian Lam, Mariko Ibaraki +7 more
2010· article· en· Experimental Hematology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
49
citations
affno abstractunlabeled
Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)
Joshua A. Kaplan, Jeroen C. Verheijen, Natasja Brooijmans, Lourdes Toral‐Barza, Irwin Hollander, Ker Yu +1 more
2009· article· en· Bioorganic & Medicinal Chemistry Letters· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
49
citations
affaboutunlabeled
Akt isoform specific effects in ovarian cancer progression
Nicolle M. Linnerth-Petrik, Lisa A. Santry, Roger A. Moorehead, Manfred Jücker, Sarah K. Wootton, Jim Petrik
2016· article· en· Oncotarget· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
49
citations

How this was built: Screen · Findings · About